Authors
Loading...
Randomized trial identifies key mutations affecting neurovirulence in reovirus type 3 variants, suggesting potential therapeutic targets.
Bassel‐Duby et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: